Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China

ZHAO Xue, SUN Li-hua

Chinese Pharmaceutical Journal ›› 2016, Vol. 51 ›› Issue (21) : 1895-1900.

PDF(823 KB)
PDF(823 KB)
Chinese Pharmaceutical Journal ›› 2016, Vol. 51 ›› Issue (21) : 1895-1900. DOI: 10.11669/cpj.2016.21.014

Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2016, 51(21): 1895-1900 https://doi.org/10.11669/cpj.2016.21.014

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(823 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉